Phibro Animal Health Corp.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
20.16%
Market Cap
-
P/E Ratio
21.53
Dividend Yield
1.88 %
Earnings per Share
1.09 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 29.8 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 09:56:39 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 30 | 29.6 |
| PREV. DAY'S PRICE | 29.8 | (07/23) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 51 (04/08) | 22 (08/01) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.77 | 0.06 | 1.09 | 2.72 | 2.90 |
DIVIDENDS PER SHARE | 0.46 | 0.44 | 0.44 | 0.42 | 0.42 |
DIVIDEND YIELD IN % | 3.50 % | 2.86 % | 1.88 % | - | - |
DIVIDEND GROWTH IN % | 7.69 % | -3.31 % | -0.52 % | - | - |
PRICE - EARNINGS RATIO | 17.02 | 281.38 | 21.53 | 11.00 | 10.32 |
PRICE - BOOK RATIO | 1.96 | 2.65 | 3.62 | - | - |
PRICE - SALES RATIO | 0.57 | 0.67 | 0.80 | - | - |
PRICE - CASH FLOW RATIO | 41.69 | 7.76 | 12.97 | - | - |
Master Data
| WKN | A1WZ6P |
| ISIN | US71742Q1067 |
| SYMBOL | PB8 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | PHIBRO ANIMAL HEALTH A |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.05 % | 12.03 % | -36.05 % | -14.37 % | 20.16 % | 122.39 % | 46.08 % | -5.10 % |
| HIGH | 30.00 | 30.40 | 49.40 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 |
| LOW | 28.20 | 27.20 | 24.20 | 24.20 | 22.00 | 8.60 | 8.60 | 24.20 |
Dividende
pro Aktie
Company profile
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
Structured products for Phibro Animal Health Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.